INR-CAD: inflammation-related coronary artery disease study
Treatments studied
Part of Heart & circulation clinical trials.
This study follows people who have both coronary artery disease (narrowed heart arteries) and signs of chronic inflammation to learn more about their condition, current treatments, and outcomes. It helps doctors understand how best to care for patients like you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have blockages in your heart arteries (at least 50% narrowing) and signs of long-term inflammation (like high blood markers for inflammation or an autoimmune disease).
- You are not newly pregnant, breastfeeding, or planning to get pregnant during the study.
- You have not been hospitalized in the last 6 months for chest pain due to a new or worsening blockage (or 12 months if you take immune-suppressing medicines).
- You do not have other serious heart conditions, active cancer, or a life expectancy shorter than 1 year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two types of coronary artery disease: one linked to inflammation (IR-CAD) and the standard type (AS-CAD). If you have had a heart procedure and were recently hospitalized for worsening chest pain, this study may help doctors understand your condition better.
This study looks at whether a comprehensive add-on treatment—starting with immune medicine and then a heart procedure when needed—can improve outcomes for people whose coronary artery disease is getting worse quickly. It focuses on cases where inflammation is likely driving new artery blockages or worsening chest pain.
This study follows adults who have fast, unexplained re-narrowing of a coronary stent, to better understand what causes it and how to monitor it. You may help by allowing the study team to collect medical information over time.
This study looks at a specific type of coronary artery disease that gets worse quickly despite treatment. It compares people who have this rapid worsening to those whose condition is stable, to learn more about the disease and possibly find better ways to manage it.
This study tests a new medicine called YMI024 for people with stable coronary artery disease (blockages in heart arteries) and higher than normal levels of inflammation. The drug aims to reduce inflammation and may lower the risk of future heart problems.
This trial builds and tests an AI system using information from a heart CT scan to help evaluate coronary artery disease (clogged heart arteries). If you need a CT coronary angiography for medical reasons, this may help improve how such scans are analyzed and used in care.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.